Asclepias Curassavica

Asclepias curassavica  Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Asclepiadaceae.
Habitat Naturalized in many parts of India as an ornamental.
English Curassavian Swallow- Wort, West Indian Ipecacuanha, Blood-Flower.
Ayurvedic Kaakanaasikaa (substitute).
Folk Kaakatundi (Kashmir).
Action Spasmogenic, cardiotonic, cytotoxic, antihaemorrhagic, styptic, antibacterial. Various plant parts, as also plant latex, are used against warts and cancer. Root—used as an astringent in piles. Leaves—juice, antidysenteric, also used against haemorrhages. Flowers—juice, styptic. Alcoholic extract of the plant—cardiotonic.
Taxonomic Cohort Genus Asclepias (1 documented species); Family Asclepiadaceae (24 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Asclepias curassavica (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Asclepiadaceae (primary family classification: Asclepiadaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Naturalized in many parts of India as an ornamental.

Across classical and vernacular Indian systems of medicine, Asclepias curassavica is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Curassavian Swallow- Wort, West Indian Ipecacuanha, Blood-Flower; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kaakanaasikaa (substitute); in regional Indian folk and vernacular ethnobotany as Kaakatundi (Kashmir). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Asclepias curassavica are: Spasmogenic, cardiotonic, cytotoxic, antihaemorrhagic, styptic, antibacterial. Various plant parts, as also plant latex, are used against warts and cancer. Root—used as an astringent in piles. Leaves—juice, antidysenteric, also used against haemorrhages. Flowers—juice, styptic. Alcoholic extract of the plant—cardiotonic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Asclepias curassavica establish the following evidence base: An alcoholic extract of the Indian plant has been reported to contain a number of cardenolides, including calactin, calotropin, calotropagenin, coroglaucigenin, uzarigenin, asclepin, its glucosides and uzarin. Asclepin, the chief active principle, is spasmogenic and a cardiac tonic, having longer duration of action than digoxin (96 h in cat, as opposed to the 72 h of digoxin). Calotropin exhibits cytotoxic activity. Pleurisy root of the U.S. is equated with Asclepias tuberosa. It is used for cold, flu and bronchitis in Western herbal medicine. Toxic principles of the herb include galitoxin and similar resins, and glucofrugoside (cardenolide). Toxicity is reduced by drying.

image2

Botanical Reference 1: Asclepias curassavica — Botanical specimen

image3

Botanical Reference 2: Asclepias curassavica — Botanical specimen

image3

Botanical Reference 3: Asclepias curassavica — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Asclepias curassavica stands as a distinct representative of the genus Asclepias. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Asclepiadaceae encompasses 24 documented medicinal species (1.32% of the 1,814-species flora). Other representative medicinal members of Asclepiadaceae include: Calotropis gigantea (Alarka), Calotropis procera (Alarka), Ceropegia juncea (Kanvel), Cryptolepis buchanani (Krishna Saarivaa), Decalepis hamiltonii. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 24 medicinal species of family Asclepiadaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Asclepias curassavica follow the plant-part modalities specified under its therapeutic action (Spasmogenic, cardiotonic, cytotoxic, antihaemorrhagic, styptic, antibacterial. Various plant parts, as also plant latex, are used against warts and cancer. Root—used as an astringent in piles. Leaves—juice, antidysenteric, also used against haemorrhages. Flowers—juice, styptic. Alcoholic extract of the plant—cardiotonic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Asclepias curassavica integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top